Moderna and Merck are collaborating on Intismeran autogene, with production planned for Laval and Canadian authorization granted.
2 reports, 1 independent
Updated Aug 23
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Merck are collaborating on Intismeran autogene, with production planned for Laval and Canadian authorization granted.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Moderna is manufacturing doses domestically in Canada.Sub-event
The Moderna-Merck collaboration is advancing, with production set for Laval and Canadian authorization granted.1 source
Keep exploring
Part of
Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.Also in this story
- Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.
- Moderna and Merck announced a landmark moment in vaccine testing, alongside updates regarding personnel at Moderna and Columbia University.
- Moderna combined its vaccine with Merck's Keytruda drug.
- Moderna, Merck, and Georgetown Lombardi Comprehensive Cancer Center are collaborating on developing a personalized cancer vaccine combination.
The entities involved
Coverage
Newest first; wire copies grouped- GuruFocus.comModerna Stock Jumps After Canada Approves New Covid Vaccine This article first appeared on GuruFocus. Aug 22 - Moderna (NASDAQ:MRNA) stock climbed more than 5% on Friday after Canada authorized its u
- Unknown outlet